Bottomline: InvAscent-backed Malladi Drugs seeks to step up growth with potential IPO in sight
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Bottomline: InvAscent-backed Malladi Drugs seeks to step up growth with potential IPO in sight

Bottomline: InvAscent-backed Malladi Drugs seeks to step up growth with potential IPO in sight

By Sreeja Biswas

  • 23 Sep 2024
Premium
Bottomline: InvAscent-backed Malladi Drugs seeks to step up growth with potential IPO in sight
Credit: Shah Junaid/VCCircle

Malladi Drugs and Pharmaceuticals Ltd, which is backed by healthcare-focused private equity firm InvAscent, is seeking .........

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.